SCHEMBL24604286

SCHEMBL24604286

CCOc1ccc(C(O)c2cnc(Cl)s2)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 4/20 0.48
TDP1 Q9NUW8 1/20 0.44
LMNA P02545 3/20 0.44
KMT2A Q03164 4/20 0.43
MEN1 O00255 3/20 0.43
CYP1A2 P05177 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
NQO1 P15559 1/20 0.41
POLB P06746 1/20 0.40
RAB9A P51151 1/20 0.40
ATM Q13315 1/20 0.40
BRD4 O60885 1/20 0.40
CREBBP Q92793 1/20 0.40
EGFR P00533 1/20 0.40
LCK P06239 1/20 0.40
NPBWR1 P48145 1/20 0.39
MCHR1 Q99705 1/20 0.39
ACACB O00763 2/20 0.38
TAAR1 Q96RJ0 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9114461 0.77 NQO1 (0.64) L3MBTL1TDP1LMNAKMT2AMEN1
SCHEMBL20919820 0.76 MAPK1 (0.42) LMNAKMT2AMEN1RAB9A
SCHEMBL31040270 0.76 SMN1; SMN2 (0.34) LMNACYP1A2CYP2C9CYP2C19RAB9A
SCHEMBL20929557 0.73 ALDH1A1 (0.31) LMNA
SCHEMBL23352202 0.73 PTGS2 (0.40) LMNAKMT2AMEN1
SCHEMBL20929610 0.72 CYP17A1 (0.35)
SCHEMBL24604285 0.71 L3MBTL1 (0.63) L3MBTL1TDP1LMNAKMT2AMEN1
SCHEMBL19867567 0.71 LMNA (0.50) L3MBTL1LMNAKMT2AMEN1NQO1
SCHEMBL11420513 0.71 LTA4H (0.57) L3MBTL1LMNAKMT2AMEN1CYP1A2
SCHEMBL31040274 0.71 MAPT (0.51) LMNAKMT2AMEN1CYP2C19POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022147210-A1 ANTI-TUMOR COMPOSITIONS AND METHODS EVRYS BIO, LLC (US) 2022-07-07 WO disclosed